{"id":"W2094364524","doi":"10.1185/03007995.2014.973939","title":"A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Novo Nordisk Canada","keywords":"Medicine; Liraglutide; Metformin; Type 2 diabetes; Clinical endpoint; Exenatide; Glycemic; Clinical trial; Internal medicine; Glucagon-like peptide 1 receptor; Hypoglycemia; Diabetes mellitus; Endocrinology; Insulin; Agonist; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1662251,0.002076136,0.01065363,0.01123537,0.0007927479,0.008790315,0.002406345,0.002819714,0.004261467],"category_scores_gemma":[0.2211154,0.00115877,0.01676822,0.01380804,0.001323569,0.004932793,0.003181258,0.00237191,0.0005021057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002240057,"about_ca_system_score_gemma":0.005542036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008588323,"about_ca_topic_score_gemma":0.002991422,"domain_scores_codex":[0.7776461,0.1504015,0.05109368,0.00563625,0.0146413,0.0005811303],"domain_scores_gemma":[0.6502806,0.2922864,0.03844997,0.006372227,0.01137645,0.001234329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.004762337,0.0001152728,0.008287982,0.678206,0.1513121,0.0001965855,0.000531806,0.0009311126,0.0008221288,0.002533137,0.001627291,0.1506743],"study_design_scores_gemma":[0.00758974,0.006117601,0.02639577,0.4405693,0.4490096,0.0008470399,0.001194142,0.001982149,0.001977909,0.01539622,0.04856339,0.0003571886],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005901067,0.9811164,0.005203144,0.001598504,0.0005070693,0.002287092,0.0009891002,0.00003947529,0.002358144],"genre_scores_gemma":[0.2492547,0.6575901,0.06517043,0.005551806,0.002182396,0.01682414,0.002302087,0.0001406056,0.0009836907],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1662251,"threshold_uncertainty_score":0.879093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2948600957030492,"score_gpt":0.5409420813016502,"score_spread":0.2460819855986011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}